Tredegar Corporation

Tredegar Corporation

NNYSE:TG
5.64
USD
-0.11
(-1.91%)
0.65EPS
10.21P/E
239.42MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
29.82
29.47
27.51
25.28
29.18
25.76
24.86
22.61
24.62
22.54
16.8
17.41
20.81
22.84
Basic EPS, GAAP
0.68
1.14
-0.99
0.75
1.16
0.75
1.45
-2.26
1.72
0.84
-3.1
-1.88
0.96
0.67
Free Cash Flow per Basic Share
2.38
1.59
2.28
1.49
2.68
2.96
3.49
2.23
2.1
-0.62
0.7
0.74
0.95
0.69
Dividend per Share
0.28
0.34
0.42
0.44
0.44
0.44
0.46
6.47
0.48
0.5
0.26
- -
- -
- -
Book Value per Share
12.46
11.47
8.35
9.44
10.41
10.7
11.29
3.26
5.49
5.95
4.54
5.24
6.26
6.48
Tangible Book Value per Share
5.46
4.84
3.66
4.84
5.3
7.15
8.17
0.67
2.97
3.53
3.23
4.38
5.45
5.71
Basic Weighted Avg Shares
32
32
33
33
33
33
33
33
34
34
34
34
35
35
Sales/Revenue/Turnover
959
952
896
828
961
852
826
755
826
762
573
598
723
794
Operating Margin (%)
5.78
6.08
5.44
3.84
4.37
6.58
5.87
7.98
7.24
1.74
-1.7
3.41
3.85
3.08
Depreciation Expense
45
41
35
32
40
34
44
32
24
26
28
26
22
21
Net Income, GAAP
22
37
-32
24
38
25
48
-75
58
28
-106
-65
33
23
Effective Tax Rate (%)
32.11
20.67
- -
11.62
- -
23.4
18.81
- -
13.83
- -
- -
- -
21.47
18.33
Profit Margin (%)
2.29
3.87
-3.59
2.95
3.98
2.92
5.84
-9.99
7
3.73
-18.47
-10.8
4.63
2.95
Working Capital
109
130
93
88
133
114
81
48
68
93
-72
48
65
90
LT Debt
139
137
104
95
152
102
59
149
86
150
10
74
46
61
Total Equity
403
372
273
311
344
355
377
109
185
202
156
181
217
225
Return on Invested Capital (%)
7.47
7.74
- -
7.02
- -
8.98
8.65
- -
22.5
- -
- -
- -
9.97
8.7
Return on Capital (%)
4.59
7.43
- -
7.11
- -
6.14
11.52
- -
22.8
- -
- -
- -
14
8.98
Return on Common Equity (%)
5.66
9.52
-9.97
8.39
11.69
7.11
13.19
-31.06
39.37
14.73
-59.26
-38.36
16.84
10.96

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
3
3
3
LT Borrowings
46
46
49
LT Finance Leases
10
12
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
35
35
Market Capitalization
277
277
239

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
203
210
200
Cash, Cash Equivalents & STI
16
17
16
Accounts Receivable, Net
91
94
94
Inventories
84
88
78
Total Current Liabilities
118
121
110
Payables & Accruals
116
119
107
ST Debt
3
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.46%
18.33%
19.66%
Free Cash Flow
-27.43%
-62.83%
29.28%
Net Income, GAAP
-120.74%
-178.1%
-151.85%
Sales/Revenue/Turnover
-1.24%
0.41%
20.88%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
144
154
146
50
598
2025
165
179
195
184
723
2026
186
216
207
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.1
0.26
-0.11
-2.12
-1.88
2025
0.29
0.05
0.2
0.42
0.96
2026
0.16
0.17
-0.08
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Arijit DasGupta
Full Time Employees
1,700
Sector
Non-energy minerals
Industry
Aluminum
Address
1100 Boulders Parkway Richmond VA United States 23225
IPO Date
Jul 5, 1989
Business
Tredegar Corporation manufactures custom aluminum extrusions and surface protection films. Aluminum Extrusions produces standard and custom extrusions for the North American building and construction, automotive, and specialty end-use markets, including structural components, automotive parts, and consumer durables; Surface Protection, through Tredegar Surface Protection, manufactures high-performance masking films that protect optical films and specialty substrates for LCD and OLED displays in the global electronics industry, as well as automotive, packaging, and other specialty applications, featuring clean room production, customizable treatments, and technologies that maximize manufacturing yields and ensure quality. The company operates manufacturing facilities in North America and Asia, employs approximately 1,500 people, and maintains headquarters in North Chesterfield, Virginia. Tredegar originated as a 1988 spin-off from Ethyl Corporation. In 2024, Tredegar completed the sale of its flexible packaging films business, Terphane, to Oben Group for approximately $116 million in base consideration, streamlining operations to focus on aluminum extrusions and surface protection films; Tredegar Surface Protection also launched Obsidian Automotive Protective Films, expanding its masking solutions for automotive surface protection.

Company News

  • Head-To-Head Contrast: Tredegar (NYSE:TG) vs. Ivanhoe Mines (OTCMKTS:IVPAF)

  • TG Stock Tumbles 19% As It Incurs Q3 Loss on Soft Construction Demand

  • Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates

  • Tredegar Reports Third Quarter 2026 Results

  • Tredegar Plans to Release Third Quarter 2026 Financial Results on November 6, 2026

  • 2 Stocks That May Benefit from Data Center Build-out

  • Tredegar Appoints Cindy Yao as Vice President, Chief Financial Officer and Treasurer

  • Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia

  • Tredegar Announces Departure of Kevin Donnelly, Executive Vice President, General Counsel and Corporate Secretary

  • Tredegar Provides Update on One Tredegar Transformation

  • BlackRock Inc. Purchases New Position in Tredegar Corporation $TG

  • Connor Clark & Lunn Investment Management Ltd. Buys New Position in Tredegar Corporation $TG

  • Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

  • Tredegar Announces Election of Ana Dutra to Board of Directors

  • Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains

  • Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why

  • Tredegar Reports Second Quarter 2026 Results

  • Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026

  • Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026

  • Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia